Literature DB >> 23685143

SRp20: an overview of its role in human diseases.

Claudia Corbo1, Stefania Orrù, Francesco Salvatore.   

Abstract

Alternative splicing in mRNA maturation has emerged as a major field of study also because of its implications in various diseases. The SR proteins play an important role in the regulation of this process. Evidence indicates that SRp20 (SFSR3), the smallest member of the SR protein family, is involved in numerous biological processes. Here we review the state-of-the-art of knowledge about the SR proteins, in particular SRp20, in terms of its function and misregulation in human diseases including cancer also in view of its potential as a therapeutic target.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23685143     DOI: 10.1016/j.bbrc.2013.05.027

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  28 in total

Review 1.  The RNAissance family: SR proteins as multifaceted regulators of gene expression.

Authors:  Jonathan M Howard; Jeremy R Sanford
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-08-22       Impact factor: 9.957

Review 2.  Quick or quality? How mRNA escapes nuclear quality control during stress.

Authors:  Gesa Zander; Heike Krebber
Journal:  RNA Biol       Date:  2017-07-31       Impact factor: 4.652

3.  Distinct mechanisms govern the phosphorylation of different SR protein splicing factors.

Authors:  Yunxin Long; Weng Hong Sou; Kristen Wing Yu Yung; Haizhen Liu; Stephanie Winn Chee Wan; Qingyun Li; Chuyue Zeng; Carmen Oi Kwan Law; Gordon Ho Ching Chan; Terrence Chi Kong Lau; Jacky Chi Ki Ngo
Journal:  J Biol Chem       Date:  2018-11-26       Impact factor: 5.157

Review 4.  The role of splicing factors in deregulation of alternative splicing during oncogenesis and tumor progression.

Authors:  Asaf Shilo; Zahava Siegfried; Rotem Karni
Journal:  Mol Cell Oncol       Date:  2014-12-01

5.  Degradation of splicing factor SRSF3 contributes to progressive liver disease.

Authors:  Deepak Kumar; Manasi Das; Consuelo Sauceda; Lesley G Ellies; Karina Kuo; Purva Parwal; Mehak Kaur; Lily Jih; Gautam K Bandyopadhyay; Douglas Burton; Rohit Loomba; Olivia Osborn; Nicholas Jg Webster
Journal:  J Clin Invest       Date:  2019-08-08       Impact factor: 14.808

6.  Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth.

Authors:  Michael Dewaele; Tommaso Tabaglio; Karen Willekens; Marco Bezzi; Shun Xie Teo; Diana H P Low; Cheryl M Koh; Florian Rambow; Mark Fiers; Aljosja Rogiers; Enrico Radaelli; Muthafar Al-Haddawi; Soo Yong Tan; Els Hermans; Frederic Amant; Hualong Yan; Manikandan Lakshmanan; Ratnacaram Chandrahas Koumar; Soon Thye Lim; Frederick A Derheimer; Robert M Campbell; Zahid Bonday; Vinay Tergaonkar; Mark Shackleton; Christine Blattner; Jean-Christophe Marine; Ernesto Guccione
Journal:  J Clin Invest       Date:  2015-11-23       Impact factor: 14.808

7.  Alternative splicing reverses the cell-intrinsic and cell-extrinsic pro-oncogenic potentials of YAP1.

Authors:  Chi Ben; Xiaojing Wu; Atsushi Takahashi-Kanemitsu; Christopher Takaya Knight; Takeru Hayashi; Masanori Hatakeyama
Journal:  J Biol Chem       Date:  2020-08-06       Impact factor: 5.157

Review 8.  MDMX (MDM4), a Promising Target for p53 Reactivation Therapy and Beyond.

Authors:  Jean-Christophe Marine; Aart G Jochemsen
Journal:  Cold Spring Harb Perspect Med       Date:  2016-07-01       Impact factor: 6.915

9.  Human Papillomavirus E2 Regulates SRSF3 (SRp20) To Promote Capsid Protein Expression in Infected Differentiated Keratinocytes.

Authors:  T Klymenko; H Hernandez-Lopez; A I MacDonald; J M Bodily; S V Graham
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

Review 10.  Emerging functions of SRSF1, splicing factor and oncoprotein, in RNA metabolism and cancer.

Authors:  Shipra Das; Adrian R Krainer
Journal:  Mol Cancer Res       Date:  2014-05-07       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.